Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by marcroberton Aug 23, 2019 3:33pm
180 Views
Post# 30060140

Beyond the fluff - look for the real reasons for weakness

Beyond the fluff - look for the real reasons for weakness2 weeks ago, ACB announced: The amended secured credit facility will consist of an additional C$160 million... The lowest PT on the street was lowered from 9 to 8 after that and the additional 160 (almost double) can add debt to the balance sheet obviously. 
The SP has been tumbling since then while APHA retains momentum. ACB might have much larger international ambitions, but this is another step towards a longer ramp to profitability, although schedule 1 bank involvement is a good sign again. 

With acb, its a long term gamble so valuation is way stretched. If you dont want that kind of long-bet exposure, you would be better with hmmj or weed or even apha assuming they have gotten rid of all the con artists.
Bullboard Posts